Pharmaceutical

AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq

AbbVie is seeking regulatory approval in the US and EU for Rinvoq as a treatment for giant cell arteritis.

Jul 16, 2024 - 04:00
AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq
AbbVie is seeking regulatory approval in the US and EU for Rinvoq as a treatment for giant cell arteritis.
Read the original article

Tags:

Previous Article

Delix plans further trials with neuroplastogen after positive Phase I data

Next Article

Conflict means millions of children are missing vaccinations, UN says

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: A fertility clinic failure destroyed my chance at motherhood

Opinion: A fertility clinic failure destroyed my chance...

Nov 7, 2023

Johnson & Johnson gains FDA and EC approvals for TB treatment

Johnson & Johnson gains FDA and EC approvals for TB tre...

Jul 4, 2024

Nearly 1 in 10 teens globally have used ‘budget Ozempic’ laxatives and other risky weight loss products, per study

Nearly 1 in 10 teens globally have used ‘budget Ozempic...

Jan 10, 2024